Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

One-year Follow-up of Iron in Basal Ganglia - R2*: a Biomarker of Parkinson's Disease Progression?

NCT02816645 is registered in ClinicalTrials.gov with University Hospital, Clermont-Ferrand as lead sponsor.

NCT NCT02816645
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02816645 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
One-year Follow-up of Iron in Basal Ganglia - R2*: a Biomarker of Parkinson's Disease Progression?
Lead sponsor
University Hospital, Clermont-Ferrand
Phase
Not applicable
Overall status
Unknown status
Start date
August 31, 2015
Completion date
February 15, 2021
Enrollment
160 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease